70 related articles for article (PubMed ID: 21067243)
1. Cancer drug-resistance and a look at specific proteins: Rho GDP-dissociation inhibitor 2, Y-box binding protein 1, and HSP70/90 organizing protein in proteomics clinical application.
Skalnikova H; Martinkova J; Hrabakova R; Halada P; Dziechciarkova M; Hajduch M; Gadher SJ; Hammar A; Enetoft D; Ekefjard A; Forsstrom-Olsson O; Kovarova H
J Proteome Res; 2011 Feb; 10(2):404-15. PubMed ID: 21067243
[TBL] [Abstract][Full Text] [Related]
2. Differential proteomic analysis of lymphocytes treated with mycophenolic acid reveals caspase 3-induced cleavage of rho GDP dissociation inhibitor 2.
Heller T; Asif AR; Petrova DT; Doncheva Y; Wieland E; Oellerich M; Shipkova M; Armstrong VW
Ther Drug Monit; 2009 Apr; 31(2):211-7. PubMed ID: 19214148
[TBL] [Abstract][Full Text] [Related]
3. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
4. [Screening proteins related to retinoic acid resistance by proteomic analysis].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.
Schunke D; Span P; Ronneburg H; Dittmer A; Vetter M; Holzhausen HJ; Kantelhardt E; Krenkel S; Müller V; Sweep FC; Thomssen C; Dittmer J
Cancer Res; 2007 Nov; 67(22):10694-702. PubMed ID: 18006811
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer.
Cho HJ; Baek KE; Kim IK; Park SM; Choi YL; Nam IK; Park SH; Im MJ; Yoo JM; Ryu KJ; Oh YT; Hong SC; Kwon OH; Kim JW; Lee CW; Yoo J
J Proteome Res; 2012 Apr; 11(4):2355-64. PubMed ID: 22364609
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.
Kusumoto H; Rodgers QE; Boege F; Raimondi SC; Beck WT
Cancer Res; 1996 Jun; 56(11):2573-83. PubMed ID: 8653700
[TBL] [Abstract][Full Text] [Related]
8. PLCγ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer.
Cho HJ; Baek KE; Nam IK; Park SM; Kim IK; Park SH; Im MJ; Ryu KJ; Yoo JM; Hong SC; Kim JW; Lee CW; Yoo J
Biochem Biophys Res Commun; 2011 Oct; 414(3):575-80. PubMed ID: 21986528
[TBL] [Abstract][Full Text] [Related]
9. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
[TBL] [Abstract][Full Text] [Related]
10. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
Yahata H; Kobayashi H; Kamura T; Amada S; Hirakawa T; Kohno K; Kuwano M; Nakano H
J Cancer Res Clin Oncol; 2002 Nov; 128(11):621-6. PubMed ID: 12458343
[TBL] [Abstract][Full Text] [Related]
11. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
Zhang B; Zhang Y; Dagher MC; Shacter E
Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic effects of a high performance liquid chromatography (HPLC) fraction of Antrodia camphorata mycelia are mediated by down-regulation of the expressions of four tumor-related genes in human non-small cell lung carcinoma A549 cell.
Chan YY; Chang CS; Chien LH; Wu TF
J Ethnopharmacol; 2010 Feb; 127(3):652-61. PubMed ID: 19995598
[TBL] [Abstract][Full Text] [Related]
13. Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine.
Kovarova H; Halada P; Man P; Dzubak P; Hajduch M
Technol Cancer Res Treat; 2002 Aug; 1(4):247-56. PubMed ID: 12625783
[TBL] [Abstract][Full Text] [Related]
14. Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphate-dissociation inhibitor (D4-GDI).
Kondoh K; Nakata Y; Yamaoka T; Itakura M; Hayashi M; Yamada K; Hata J; Yamada T
Int Immunol; 2008 Oct; 20(10):1299-311. PubMed ID: 18689726
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study.
Verrills NM; Liem NL; Liaw TY; Hood BD; Lock RB; Kavallaris M
Proteomics; 2006 Mar; 6(5):1681-94. PubMed ID: 16456880
[TBL] [Abstract][Full Text] [Related]
16. Shotgun proteomics and network analysis of neuroblastoma cell lines treated with curcumin.
D'Aguanno S; D'Agnano I; De Canio M; Rossi C; Bernardini S; Federici G; Urbani A
Mol Biosyst; 2012 Apr; 8(4):1068-77. PubMed ID: 22315092
[TBL] [Abstract][Full Text] [Related]
17. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line.
Yang YX; Chen ZC; Zhang GY; Yi H; Xiao ZQ
J Cell Biochem; 2008 Jun; 104(3):1010-21. PubMed ID: 18253933
[TBL] [Abstract][Full Text] [Related]
18. Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.
Kovárová H; Hajdúch M; Korínková G; Halada P; Krupicková S; Gouldsworthy A; Zhelev N; Strnad M
Electrophoresis; 2000 Nov; 21(17):3757-64. PubMed ID: 11271495
[TBL] [Abstract][Full Text] [Related]
19. Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia.
Brozovic A; Simaga S; Osmak M
Neoplasma; 2001; 48(2):99-103. PubMed ID: 11478701
[TBL] [Abstract][Full Text] [Related]
20. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
Ohga T; Koike K; Ono M; Makino Y; Itagaki Y; Tanimoto M; Kuwano M; Kohno K
Cancer Res; 1996 Sep; 56(18):4224-8. PubMed ID: 8797596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
